These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39141133)

  • 1. A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury.
    Zou S; Xu J; Yang W; Chen Z; Shan H; Liu J; Tian D; Wu X; Du Q; Dong X; Jiang L
    Neurosurg Rev; 2024 Aug; 47(1):433. PubMed ID: 39141133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study.
    Wu X; Su C; Tian D; Ye Y; Du Q; Chen J; Li H; Liu J
    Brain Behav; 2024 May; 14(5):e3522. PubMed ID: 38773776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of AIM2 as a serum marker for reflecting severity and predicting a poor outcome of human severe traumatic brain injury: A prospective longitudinal cohort study.
    Chen SH; Hu FL; Wang G; Liang XS; He CJ
    Clin Chim Acta; 2024 Jun; 559():119691. PubMed ID: 38685373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective observational study on utility of serum mesencephalic astrocyte-derived neurotrophic factor as a promising prognostic biomarker of severe traumatic brain injury in humans.
    Wang KW; Zhan CP; Liu YQ; Fu ZZ; Qiu TW; Yu GF
    Clin Chim Acta; 2023 May; 545():117370. PubMed ID: 37137461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal change of serum xanthine oxidase levels and its relation to clinical outcome of severe traumatic brain injury: a prospective cohort study.
    Yan T; Shan H; Wang Z; Zou S; Chen Z; Yu W; Du Q; Dong X
    Neurosurg Rev; 2023 Dec; 46(1):320. PubMed ID: 38038775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of serum IRAK3 as a biochemical marker in relation to severity and neurological outcome of human severe traumatic brain injury: A prospective longitudinal cohort study.
    Yang K; Yang L; Chen X; Li J; Zheng B; Hu J; Wang H; Yu Q; Song G
    Clin Chim Acta; 2024 Jan; 553():117754. PubMed ID: 38169195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Biomarkers in severe traumatic brain injury: enhancing prognostic accuracy and therapeutic strategies".
    Nadeem M; Shahzad UB; Ahmed M; Khan MAF
    Neurosurg Rev; 2024 Sep; 47(1):608. PubMed ID: 39271500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum calprotectin as a prognostic predictor in severe traumatic brain injury.
    Yang Y; Shen L; Xu M; Chen L; Lu W; Wang W
    Clin Chim Acta; 2021 Sep; 520():101-107. PubMed ID: 34102135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of serum nuclear factor erythroid 2-related factor 2 as a potential prognostic biomarker of severe traumatic brain injury in adults: A prospective cohort study.
    Yan XJ; Zhan CP; Lv Y; Mao DD; Zhou RC; Xv YM; Yu GF
    Front Neurol; 2022; 13():1013062. PubMed ID: 36388174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Serum NLRC4 as a Potential Prognostic Biochemical Marker in Humans with Severe Traumatic Brain Injury: A Prospective Cohort Study.
    Tang B; Zhong Z; Wu J; Ma J; Li L; Zhong X; Lin D; Hu J; Yu P
    Risk Manag Healthc Policy; 2023; 16():439-454. PubMed ID: 36994425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Longitudinal Cohort Study of Serum Stanniocalcin-1 as a Potential Prognostic Biomarker of Severe Traumatic Brain Injury.
    Jin C; Huang X; Hu Y; Xu B; Ma J
    Ther Clin Risk Manag; 2024; 20():341-361. PubMed ID: 38884106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study.
    Zhang H; Lv QW; Zheng ZQ; Shen LJ; Zhou J; Guo M
    Neuropsychiatr Dis Treat; 2023; 19():153-169. PubMed ID: 36698699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors of severe traumatic brain injury and the predictive value of serum translocator protein combined with the reverse shock index multiplied by Glasgow Coma Scale].
    Chen X; Zhu L
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(3):218-223. PubMed ID: 33455149
    [No Abstract]   [Full Text] [Related]  

  • 15. Simplifying the use of prognostic information in traumatic brain injury. Part 2: Graphical presentation of probabilities.
    Murray GD; Brennan PM; Teasdale GM
    J Neurosurg; 2018 Jun; 128(6):1621-1634. PubMed ID: 29631517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the editor: "A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury".
    Tamil Selvan S
    Neurosurg Rev; 2024 Oct; 47(1):739. PubMed ID: 39373745
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance.
    Tang B; Zhong Z; Qiu Z; Wu HP; Hu JY; Ma JP; Wu JP
    Clin Chim Acta; 2019 Aug; 495():227-232. PubMed ID: 31009601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplifying the use of prognostic information in traumatic brain injury. Part 1: The GCS-Pupils score: an extended index of clinical severity.
    Brennan PM; Murray GD; Teasdale GM
    J Neurosurg; 2018 Jun; 128(6):1612-1620. PubMed ID: 29631516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study on serum secreted protein acidic and rich in cysteine-like 1 as a prognostic marker for severe traumatic brain injury.
    Huang HB; Yang SB; Shen LJ; Lv QW; Guo M; Zhou J; Li Z; Yang CS; Wang LY; Zhang H
    Clin Chim Acta; 2019 Apr; 491():19-23. PubMed ID: 30639238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sulfonylurea receptor-1 as a biomarker of clinical severity and prognosis in patients with traumatic brain injury.
    Ying X; Chen M; Zhang J; Sun CF; Zhou J
    Clin Chim Acta; 2022 Mar; 528():65-73. PubMed ID: 35092725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.